MRI Compatible Patient Monitoring Systems Market

MRI Compatible Patient Monitoring Systems Market Outlook (2022 to 2032)

The global MRI compatible patient monitoring systems market holds a forecasted share of USD 3,851.4 million in 2022 and is likely to surpass USD 5,958.6 million by 2032, moving ahead with a CAGR of 4% during the forecast period.

Magnetic Resonance Imaging (MRI) is a valuable diagnostic tool for identifying diseases related to spine lesions, tumors, and strokes affecting the blood vessels and the brain. The prevalence of these diseases is driving the growth of the MRI compatible patient monitoring systems market.

Report Attribute	Details
MRI Compatible Patient Monitoring Systems Market Value (2022)	USD 3,851.4 million
MRI Compatible Patient Monitoring Systems Market Anticipated Forecast Value (2032)	USD 5,958.6 million
MRI Compatible Patient Monitoring Systems Market Projected Growth Rate (2022 to 2032)	4%

In 2020, the International Agency for Research on Cancer reported 19,292,789 new cancer cases worldwide. MRI machines are expected to be widely adopted due to the growing demand for quick and effective diagnostic procedures. Various countries are installing these MRI machines. According to the OECD, 34.54 MRI units were installed in the USA in 2020. Artificial intelligence may also have a positive impact on the market in the future.

MRI compatible patient monitoring systems are technologically modified and equipped with safety features, such as alarms or other operator alerts that are meant to trigger in the event of a problem, thus shaping key trends and opportunities in the market for MRI compatible patient monitoring systems.

There has been a tremendous amount of advancement in MRI technology over recent years, especially in the software field. It has also been driven by advancements in diagnostic techniques such as open MRI, visualization software, and superconducting magnets. Furthermore, the development of cardiac pacemaker-compatible MRI systems is expected to propel market growth in the cardiology segment.

Further, various paramagnetic contrast agents, such as gadolinium-DTPA, can be injected intravenously to provide sharp, precise, and accurate images within a short period. As a result of these technological advancements in MRI, market growth is expected to accelerate during the forecast period.

MRI manufacturers have continued to adopt newer technology and develop artificial intelligence (AI)-based solutions to increase the market growth. Radiologists used this to understand chronic diseases and residual symptoms more effectively and efficiently. MRI is expected to play a key role in patient monitoring as clinicians seek to find out what is causing long-term chronic disease symptoms

Several recent advancements, such as diffusion and diffusion tensor imaging with tractography, neuroimaging such as MR spectroscopy, perfusion imaging, and functional imaging utilizing the bold technique, are expected to boost market growth during the forecast period.

It is also expected that the market will grow as intraoperative MRI grows in popularity and is applied in several applications, including neurosurgery.

There are several advantages associated with MRI systems, but the costs associated with purchasing and installing such machines are quite high, which in turn affects the growth of the market, particularly in developing regions. Low- to medium-strength MRI machines cost more than one million dollars on average.

Furthermore, helium gas is depleting at an alarming rate, resulting in increased wait time and a reduction in productivity.

The growth of the market is also negatively impacted by the delayed approval of products and frequent recalls of products primarily because of stringent regulatory frameworks.

What are the Key MRI Compatible Patient Monitoring Systems Market Dynamics?

Drivers:

• Increase in Prevalence of Chronic Disorders: As chronic diseases become more prevalent, the global market for MRI compatible patient monitoring systems is expected to grow. For instance, specifically, the American Cancer Society estimates that the USA will suffer from 1.9 million new cancer cases and 609,360 cancer deaths in 2022.
• Launch of New Products: Over the forecast period, key market players are expected to launch more products to drive growth in the global MRI compatible patient monitoring systems market. For example, Cannon Medical, a medical equipment company, launched a new MRI system in July 2022 at the ECR (European Congress of Radiology) 2022 conference. MRI procedures are shortened with the new system because it incorporates innovative workflow solutions, image enhancement, and faster scan technologies.
• Growing access to compatible medical services will likely fuel the demand for MRI compatible patient monitoring systems as large volumes of patients undergo MRI procedures.

Restraints:

It is anticipated that mixed results with MRI screening may hinder the growth of the global MRI compatible patient monitoring systems market. For instance, in November 2019, researchers at Utrecht University Medical Center, The Netherlands, published a study finding that the rate of interval cancers was reduced by half in patients with dense breast tissue when mammography was complemented with magnetic resonance imaging (MRI). However, there was a significant rate of recall for additional imaging.

Some factors will limit the growth of the MRI compatible patient monitoring system market in the future. These factors include the risk associated with MRI scans, the strict regulatory requirements for approving devices, and the high cost of devices. An MRI examination takes a considerable amount of time, and critically ill patients and children are sometimes sedated during the procedure.

Medical conditions like respiratory depression and hypoxemia can sometimes result from these scans. According to the Safety Committee of the Society for Magnetic Resonance Imaging, MRI procedures should be physiologically monitored and performed only by a qualified professional.

Opportunities:

There may be ample growth opportunities for players in the MRI compatible patient monitoring system market in several unexplored markets in emerging economies. By monitoring the patient's vital signs, these systems help to avoid any emergencies during the scan. Among the vital signs that can be monitored with these systems are electrocardiography, pulse oximetry, and invasive blood pressure (IBP).

Further, these systems can be used to monitor pediatric patients, patients who are mentally ill, and critically ill patients, as well as patients with compromised physiologic functions. In this way, the players may be able to expand their product portfolios as the number of applications for these systems grows.

Regional Analysis

How is North America Dominating the MRI Compatible Patient Monitoring Systems Market?

With a market share of 35.2% in 2022, North America is expected to dominate the MRI compatible patient monitoring systems market. As a result of an increasing geriatric population, lifestyle-associated diseases, and the adoption of technologically advanced devices, North America may dominate the global MRI compatible patient monitoring system market in the years to come.

As medical infrastructure and reimbursement facilities develop along with technological advancements, the North American MRI compatible patient monitoring systems market is expected to register significant growth over the forecast period.

The North American MRI compatible patient monitoring system market size is expected to grow due to high healthcare spending and rising chronic disease prevalence.

The European MRI Compatible Patient Monitoring Systems Market is a Promising One.

Europe is expected to contribute modestly to the market, as well as a healthy growth rate, with MRI compatible patient monitoring systems occupying 31.9% of the market in 2022.

With an increase in elderly people and growing awareness about MRI compatible patient monitoring systems, the European MRI compatible patient monitoring systems market is expected to grow. In fact, 47% of the four million deaths there each year are caused by cardiovascular diseases, according to the European Society of Cardiology, a non-profit medical organization.

How is the Start-up Ecosystem in the MRI Compatible Patient Monitoring Systems Market?

In developing economies, favorable government policies for start-up companies like medical device manufacturers and new manufacturing facilities support capacity expansion by leading manufacturers.

The Butterfly iQ, created by Butterfly Network, is a portable, handheld ultrasound imaging device with a built-in battery and wireless charging that can perform scans for more than two hours. Butterfly Network was founded in 2011.

Additionally, it enables the organization, searching, and access of cloud-based studies via mobile or web. Several prominent investors have contributed to the raising of USD 350 million raised by this start-up, triggering new trends in the market for MRI-compatible patient monitoring systems.

MRI Compatible Patient Monitoring Systems Market: Competitive Landscape

MRI Compatible Patient Monitoring Systems Market: Key Contracts/ Agreements/ Acquisitions/ Recent Developments

To increase the adoption and usage of MRI machines in the field of medical imaging, key players are developing machines with high field strength. Aside from expansions of their regional and service portfolios, these players are also undertaking mergers and acquisitions.

• In June 2021, Philips announced a strategic partnership with Akumin Inc., a leading outpatient diagnostic imaging provider in the United States, to utilize Philips' new Radiology Operations Command Center across Akumin's outpatient imaging centers and to establish clinical standards for Akumin's MR and CT imaging technologies.

• As part of the ECR (European Congress of Radiology) 2021 meeting, Hitachi, Ltd., a Japanese multinational conglomerate corporation, announced the launch of two upgraded open MRIs, the APERTO Lucent Plus 0.4T permanent open MRI and the AIRIS Vento Plus 0.3T permanent open MRI. With Synergy Drive workflow solutions, the latest MRI systems optimize workflow and reduce scan times. From the beginning of the MRI scanning procedure to the post-processing and sharing of MRI images, the Synergy Drive workflow solution helps overcome barriers to MRI scanning.
• Philips announced the launch of an AI-enabled MR imaging portfolio in November 2021, aimed at improving the efficiency and sustainability of radiology operations by speeding up MR exams, streamlining workflows, increasing diagnostic quality, and ensuring radiology operations are efficient and sustainable.
• FUJIFILM Healthcare released its Velocity MRI System in December 2021, which features a high-field open gantry. This advanced and high-field MRI system streamlines operations and improves the patient experience.

Who are the Key Players in the MRI Compatible Patient Monitoring Systems Market?

• Arcomed AG
• PULSION Medical Systems SE
• LiDCO Group PLC
• CAS Medical Systems
• Deltex Medical Group PLC
• Philips Medical Systems
• GE Healthcare
• Draeger Medical, Inc.
• Schwarzer Cardiotek GmbH
• Tensys Medical, Inc.

Report Scope

Report Attribute	Details
Growth Rate	CAGR of 4% from 2022 to 2032
Base Year for Estimation	2022
Historical Data	2016 to 2021
Forecast Period	2022 to 2032
Quantitative Units	Revenue in USD Million and CAGR from 2022 to 2032
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered	Product Type, Modality Type, Application, End Use, Region
Regions Covered	North America; Latin America; The Asia Pacific; Middle East and Africa(MEA); Europe
Key Countries Profiled	USA, Canada, Brazil, Argentina, Germany, United Kingdom, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, GCC Countries, South Africa
Key Companies Profiled	Arcomed AG; PULSION Medical Systems SE; LiDCO Group PLC; CAS Medical Systems; Deltex Medical Group PLC; Philips Medical Systems; GE Healthcare; Draeger Medical, Inc.; Schwarzer Cardiotek GmbH; Tensys Medical, Inc.
Customization	Available Upon Request

Table of Content

• 1. Executive Summary | MRI Compatible Patient Monitoring Systems Market
• 2. Market Overview
• 3. Market Background
• 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
• 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type
  • 5.1. Magnetic Devices
  • 5.2. Non-magnetic Devices
• 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Modality Type
  • 6.1. Portable
  • 6.2. Non-portable
• 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application
  • 7.1. Blood Glucose Monitoring
  • 7.2. EEG and ECG Monitoring
  • 7.3. Capnography Monitoring
  • 7.4. Spirometer Monitoring
  • 7.5. Sleep Apnea Monitoring
  • 7.6. Pulse Oximeter Monitoring
  • 7.7. Fetal Doppler Monitoring
  • 7.8. Multi-parameter Monitoring
  • 7.9. Weight Monitoring
  • 7.10. Temperature Monitoring
  • 7.11. Other Applications
• 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
  • 8.1. Hospitals
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Diagnostics Centers
  • 8.4. Emergency Medical Services
  • 8.5. Others
• 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
  • 9.1. North America
  • 9.2. Latin America
  • 9.3. Europe
  • 9.4. Asia Pacific
  • 9.5. Middle East and Africa (MEA)
• 10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
• 11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
• 12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
• 13. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
• 14. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
• 15. Key Countries Market Analysis
• 16. Market Structure Analysis
• 17. Competition Analysis
  • 17.1. iRadimed Corporation
  • 17.2. Fresenius Kabi AG
  • 17.3. B. Braun Melsungen AG
  • 17.4. Becton, Dickinson Company
  • 17.5. Smiths Medical
  • 17.6. Baxter International Inc.
  • 17.7. Arcomed AG
  • 17.8. Deltex Medical Group Plc.
  • 17.9. Philips Medical Systems
  • 17.10. GE Healthcare
  • 17.11. Draeger Medical, Inc.
  • 17.12. Schwarzer Cardiotek GmbH
  • 17.13. Tensys Medical, Inc.
• 18. Assumptions & Acronyms Used
• 19. Research Methodology

List of Tables

Table 01: Global Market Value (US$ Million) Forecast by Region, 2017 to 2032

Table 02: Global Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 03: Global Market Value (US$ Million) Forecast by Modality Type, 2017 to 2032

Table 04: Global Market Value (US$ Million) Forecast by Application, 2017 to 2032

Table 05: Global Market Value (US$ Million) Forecast by End User, 2017 to 2032

Table 06: North America Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 07: North America Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 08: North America Market Value (US$ Million) Forecast by Modality Type, 2017 to 2032

Table 09: North America Market Value (US$ Million) Forecast by Application, 2017 to 2032

Table 10: North America Market Value (US$ Million) Forecast by End User, 2017 to 2032

Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 12: Latin America Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 13: Latin America Market Value (US$ Million) Forecast by Modality Type, 2017 to 2032

Table 14: Latin America Market Value (US$ Million) Forecast by Application, 2017 to 2032

Table 15: Latin America Market Value (US$ Million) Forecast by End User, 2017 to 2032

Table 16: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 17: Europe Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 18: Europe Market Value (US$ Million) Forecast by Modality Type, 2017 to 2032

Table 19: Europe Market Value (US$ Million) Forecast by Application, 2017 to 2032

Table 20: Europe Market Value (US$ Million) Forecast by End User, 2017 to 2032

Table 21: Asia Pacific Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 22: Asia Pacific Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 23: Asia Pacific Market Value (US$ Million) Forecast by Modality Type, 2017 to 2032

Table 24: Asia Pacific Market Value (US$ Million) Forecast by Application, 2017 to 2032

Table 25: Asia Pacific Market Value (US$ Million) Forecast by End User, 2017 to 2032

Table 26: MEA Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 27: MEA Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 28: MEA Market Value (US$ Million) Forecast by Modality Type, 2017 to 2032

Table 29: MEA Market Value (US$ Million) Forecast by Application, 2017 to 2032

Table 30: MEA Market Value (US$ Million) Forecast by End User, 2017 to 2032

List of Figures

Figure 01: Global Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 02: Global Market Value (US$ Million) by Modality Type, 2022 to 2032

Figure 03: Global Market Value (US$ Million) by Application, 2022 to 2032

Figure 04: Global Market Value (US$ Million) by End User, 2022 to 2032

Figure 05: Global Market Value (US$ Million) by Region, 2022 to 2032

Figure 06: Global Market Value (US$ Million) Analysis by Region, 2017 to 2032

Figure 07: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032

Figure 08: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032

Figure 09: Global Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 10: Global Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 11: Global Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 12: Global Market Value (US$ Million) Analysis by Modality Type, 2017 to 2032

Figure 13: Global Market Value Share (%) and BPS Analysis by Modality Type, 2022 to 2032

Figure 14: Global Market Y-o-Y Growth (%) Projections by Modality Type, 2022 to 2032

Figure 15: Global Market Value (US$ Million) Analysis by Application, 2017 to 2032

Figure 16: Global Market Value Share (%) and BPS Analysis by Application, 2022 to 2032

Figure 17: Global Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032

Figure 18: Global Market Value (US$ Million) Analysis by End User, 2017 to 2032

Figure 19: Global Market Value Share (%) and BPS Analysis by End User, 2022 to 2032

Figure 20: Global Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032

Figure 21: Global Market Attractiveness by Product Type, 2022 to 2032

Figure 22: Global Market Attractiveness by Modality Type, 2022 to 2032

Figure 23: Global Market Attractiveness by Application, 2022 to 2032

Figure 24: Global Market Attractiveness by End User, 2022 to 2032

Figure 25: Global Market Attractiveness by Region, 2022 to 2032

Figure 26: North America Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 27: North America Market Value (US$ Million) by Modality Type, 2022 to 2032

Figure 28: North America Market Value (US$ Million) by Application, 2022 to 2032

Figure 29: North America Market Value (US$ Million) by End User, 2022 to 2032

Figure 30: North America Market Value (US$ Million) by Country, 2022 to 2032

Figure 31: North America Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 34: North America Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 35: North America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 36: North America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 37: North America Market Value (US$ Million) Analysis by Modality Type, 2017 to 2032

Figure 38: North America Market Value Share (%) and BPS Analysis by Modality Type, 2022 to 2032

Figure 39: North America Market Y-o-Y Growth (%) Projections by Modality Type, 2022 to 2032

Figure 40: North America Market Value (US$ Million) Analysis by Application, 2017 to 2032

Figure 41: North America Market Value Share (%) and BPS Analysis by Application, 2022 to 2032

Figure 42: North America Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032

Figure 43: North America Market Value (US$ Million) Analysis by End User, 2017 to 2032

Figure 44: North America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032

Figure 45: North America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032

Figure 46: North America Market Attractiveness by Product Type, 2022 to 2032

Figure 47: North America Market Attractiveness by Modality Type, 2022 to 2032

Figure 48: North America Market Attractiveness by Application, 2022 to 2032

Figure 49: North America Market Attractiveness by End User, 2022 to 2032

Figure 50: North America Market Attractiveness by Country, 2022 to 2032

Figure 51: Latin America Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 52: Latin America Market Value (US$ Million) by Modality Type, 2022 to 2032

Figure 53: Latin America Market Value (US$ Million) by Application, 2022 to 2032

Figure 54: Latin America Market Value (US$ Million) by End User, 2022 to 2032

Figure 55: Latin America Market Value (US$ Million) by Country, 2022 to 2032

Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 59: Latin America Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 60: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 62: Latin America Market Value (US$ Million) Analysis by Modality Type, 2017 to 2032

Figure 63: Latin America Market Value Share (%) and BPS Analysis by Modality Type, 2022 to 2032

Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Modality Type, 2022 to 2032

Figure 65: Latin America Market Value (US$ Million) Analysis by Application, 2017 to 2032

Figure 66: Latin America Market Value Share (%) and BPS Analysis by Application, 2022 to 2032

Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032

Figure 68: Latin America Market Value (US$ Million) Analysis by End User, 2017 to 2032

Figure 69: Latin America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032

Figure 70: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032

Figure 71: Latin America Market Attractiveness by Product Type, 2022 to 2032

Figure 72: Latin America Market Attractiveness by Modality Type, 2022 to 2032

Figure 73: Latin America Market Attractiveness by Application, 2022 to 2032

Figure 74: Latin America Market Attractiveness by End User, 2022 to 2032

Figure 75: Latin America Market Attractiveness by Country, 2022 to 2032

Figure 76: Europe Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 77: Europe Market Value (US$ Million) by Modality Type, 2022 to 2032

Figure 78: Europe Market Value (US$ Million) by Application, 2022 to 2032

Figure 79: Europe Market Value (US$ Million) by End User, 2022 to 2032

Figure 80: Europe Market Value (US$ Million) by Country, 2022 to 2032

Figure 81: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 84: Europe Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 85: Europe Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 86: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 87: Europe Market Value (US$ Million) Analysis by Modality Type, 2017 to 2032

Figure 88: Europe Market Value Share (%) and BPS Analysis by Modality Type, 2022 to 2032

Figure 89: Europe Market Y-o-Y Growth (%) Projections by Modality Type, 2022 to 2032

Figure 90: Europe Market Value (US$ Million) Analysis by Application, 2017 to 2032

Figure 91: Europe Market Value Share (%) and BPS Analysis by Application, 2022 to 2032

Figure 92: Europe Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032

Figure 93: Europe Market Value (US$ Million) Analysis by End User, 2017 to 2032

Figure 94: Europe Market Value Share (%) and BPS Analysis by End User, 2022 to 2032

Figure 95: Europe Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032

Figure 96: Europe Market Attractiveness by Product Type, 2022 to 2032

Figure 97: Europe Market Attractiveness by Modality Type, 2022 to 2032

Figure 98: Europe Market Attractiveness by Application, 2022 to 2032

Figure 99: Europe Market Attractiveness by End User, 2022 to 2032

Figure 100: Europe Market Attractiveness by Country, 2022 to 2032

Figure 101: Asia Pacific Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 102: Asia Pacific Market Value (US$ Million) by Modality Type, 2022 to 2032

Figure 103: Asia Pacific Market Value (US$ Million) by Application, 2022 to 2032

Figure 104: Asia Pacific Market Value (US$ Million) by End User, 2022 to 2032

Figure 105: Asia Pacific Market Value (US$ Million) by Country, 2022 to 2032

Figure 106: Asia Pacific Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 107: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 108: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 109: Asia Pacific Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 110: Asia Pacific Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 111: Asia Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 112: Asia Pacific Market Value (US$ Million) Analysis by Modality Type, 2017 to 2032

Figure 113: Asia Pacific Market Value Share (%) and BPS Analysis by Modality Type, 2022 to 2032

Figure 114: Asia Pacific Market Y-o-Y Growth (%) Projections by Modality Type, 2022 to 2032

Figure 115: Asia Pacific Market Value (US$ Million) Analysis by Application, 2017 to 2032

Figure 116: Asia Pacific Market Value Share (%) and BPS Analysis by Application, 2022 to 2032

Figure 117: Asia Pacific Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032

Figure 118: Asia Pacific Market Value (US$ Million) Analysis by End User, 2017 to 2032

Figure 119: Asia Pacific Market Value Share (%) and BPS Analysis by End User, 2022 to 2032

Figure 120: Asia Pacific Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032

Figure 121: Asia Pacific Market Attractiveness by Product Type, 2022 to 2032

Figure 122: Asia Pacific Market Attractiveness by Modality Type, 2022 to 2032

Figure 123: Asia Pacific Market Attractiveness by Application, 2022 to 2032

Figure 124: Asia Pacific Market Attractiveness by End User, 2022 to 2032

Figure 125: Asia Pacific Market Attractiveness by Country, 2022 to 2032

Figure 126: MEA Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 127: MEA Market Value (US$ Million) by Modality Type, 2022 to 2032

Figure 128: MEA Market Value (US$ Million) by Application, 2022 to 2032

Figure 129: MEA Market Value (US$ Million) by End User, 2022 to 2032

Figure 130: MEA Market Value (US$ Million) by Country, 2022 to 2032

Figure 131: MEA Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 132: MEA Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 133: MEA Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 134: MEA Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 135: MEA Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 136: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 137: MEA Market Value (US$ Million) Analysis by Modality Type, 2017 to 2032

Figure 138: MEA Market Value Share (%) and BPS Analysis by Modality Type, 2022 to 2032

Figure 139: MEA Market Y-o-Y Growth (%) Projections by Modality Type, 2022 to 2032

Figure 140: MEA Market Value (US$ Million) Analysis by Application, 2017 to 2032

Figure 141: MEA Market Value Share (%) and BPS Analysis by Application, 2022 to 2032

Figure 142: MEA Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032

Figure 143: MEA Market Value (US$ Million) Analysis by End User, 2017 to 2032

Figure 144: MEA Market Value Share (%) and BPS Analysis by End User, 2022 to 2032

Figure 145: MEA Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032

Figure 146: MEA Market Attractiveness by Product Type, 2022 to 2032

Figure 147: MEA Market Attractiveness by Modality Type, 2022 to 2032

Figure 148: MEA Market Attractiveness by Application, 2022 to 2032

Figure 149: MEA Market Attractiveness by End User, 2022 to 2032

Figure 150: MEA Market Attractiveness by Country, 2022 to 2032